Acumen Research and Consulting estimates that global Infection Prevention Devices market is expected to reach the market value of around US$ 7.1 Bn by 2028 and is anticipated to grow at a CAGR of around 4.3% in terms of revenue amid the forecast period 2021 - 2028.
Collection of consumables, disposable devices and medical equipment used to prevent the prevalence of infection in patients and in workers in different health care facilities are known as infection prevention devices.
The report provides analysis of global Infection Prevention Devices market for the period 2017-2028, wherein 2021to 2028 is the forecast period and 2020 is considered as the base year.
Continued spending from multiple healthcare agencies, and is expected to lead to the development of their skills and services.
Greater emphasis on preventing global diseases and disorders rather than cure can boost this market's growth.
Concerns over antibiotic resistance incident and the weakened development of antibiotics, requiring improved antibiotic production, are also a driver of the market.
The demand growth is projected to be driven by high growth rates in addition to the geriatric population most likely to live longer in the hospital. The growth of the market is pushing rising numbers of surgical procedures and the growing geriatric population. The growth in infectious disease and technical advancements in sterilizing systems were expected to further raise over the projected period the total global demand for infection prevention devices
Enhanced generation of geriatric communities
Hospitals segment continue to expand due to the growing geriatric population and the rising prevalence of chronic diseases in the elderly create industry player’s chances for infection prevention tools. Managing infections in hospitals is becoming an integral aspect of health care and emphasis is being centered on next-generation infection control tools.
Continuing to raise demand for antibiotics
Emergent species are increasingly stronger, and resistant to antibiotics, while health care continues to evolve. As a global health problem, antibiotic resistance arises. Alternative approaches include novel, expensive antibiotics or phage therapy. This ensures that the most important method of combating this health issue remains infection prevention and management.
Treatment in other settings at hospital level
The creation of personalized patient care and emergency care and primary care clinics reflects the growth of hospital-level care. Infection control supplies and equipment to mitigate or eliminate pathological spreads are needed in organizations that follow this pathway. The advent of smart, secure healthcare services would potentially create a high demand for tools for infection prevention.
Infection control systems continue to gain traction in a variety of end-use applications and the growing number of operations continue to give this company a growth opportunity. However, the health sector is developing and patients receive next-generation therapies and therapies which reduce their residence in the hospital and therefore minimize the need for devices for infection prevention. This can inhibit the growth of the market for infection prevention products.
Owing to the extreme epidemic of COVID-19, global demand for specialized treatment care, equipment and facilities to treat sick people is unparalleled. The demand of most countries around the world for an increase in COVID-19 patients as one of the central areas of health care is growing, including personal protective equipment. Health professionals rely on individually protective devices to deter contamination and transmission for themselves and their patients. However, the significantly growing COVID-19 pandemic crisis does not compensate for the available facial masks and apparel capabilities and the world health industry faces a scarcity. The World Health Organization (WHO) reports that there will be a need for 89 million surgical masks per month. In order to satisfy this demand, production is expected to increase by 40%. The WHO also reports that frontline employees need approximately 7-10% and probably more of the world's supply of organizational masks. This number is as high as 76 Mn for examination gloves, while international demand for gloves hits 1,6 million per month.
North America is the leading region for infection prevention products in 2020, followed by Asia Pacific. This is because of the rise in surgery and referral to hospitals. Some of the other factors driving market growth in this area include ongoing strategic alliances by key players in extending their drug and infection prevention programs. The emergency care clinics and primary care clinics have been developed and personalized patient care reflect an expansion in hospital-level patient care. Infection control supplies and equipment to mitigate or eliminate pathological spreads are needed in organizations that follow this pathway. The development in North America of these compact and effective health centers is expected to generate a significant market for tools for infection prevention.
Key Players & Strategies
Participants include major global players Medline Industries Inc, Advanced Sterilization Products, B. Braun Melsungen AG, Cardinal Health, PAUL HARTMANN AG, Hollister Incorporated, ANSELL LTD., The Clorox Company, Cantel Medical, Contec Healthcare, Getinge AB, Coloplast A/S, BD Ahlstrom-Munksjö, and others.
Infection Prevention Devices Market By Product
Medical Waste Disposable Devices
Infection Prevention Supplies
Infection Prevention Equipment
Infection Prevention Devices Market By End Use
Life science Industries
Infection Prevention Devices Market By Geography
The Infection Prevention Devices market value is anticipated to be worth around US$ 7.1 Bn in 2028.
The Infection Prevention Devices market is anticipated to grow around 4.3% CAGR amid the forecast period 2021-2028.
North America held highest market share in 2020.
Asia Pacific is projected to be the fastest growing region in the global market.
Medline Industries Inc, Advanced Sterilization Products; B. Braun Melsungen AG, Cardinal Health, PAUL HARTMANN AG, Hollister Incorporated, ANSELL LTD., The Clorox Company, Cantel Medical, Contec Healthcare, Getinge AB, Coloplast A/S, BD Ahlstrom-Munksjö ,and others are the prominent players in the Infection Prevention Devices market.
The report provides insights on global Infection Prevention Devices market segment by product, end use and major geographic regions.
The Infection Prevention Devices market is segmented into North America, Europe, Asia Pacific, Latin America and The Middle East & Africa (LAMEA).